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Abstract 
One strategy developed by bacteria to resist the action of β-lactam antibiotics is the expression of metallo-β-
lactamases. CphA from Aeromonas hydrophila is a member of a clinically important subclass of metallo-β-
lactamases that have only one zinc ion in their active site and for which no structure is available. The crystal 
structures of wild-type CphA and its N220G mutant show the structural features of the active site of this enzyme, 
which is modeled specifically for carbapenem hydrolysis. The structure of CphA after reaction with a 
carbapenem substrate, biapenem, reveals that the enzyme traps a reaction intermediate in the active site. These 
three X-ray structures have allowed us to propose how the enzyme recognizes carbapenems and suggest a 
mechanistic pathway for hydrolysis of the β-lactam. This will be relevant for the design of metallo-β-lactamase 
inhibitors as well as of antibiotics that escape their hydrolytic activity. 
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β-Lactam antibiotics have been used successfully for several decades to target the enzymes involved in the last 
step of peptidoglycan synthesis. Nowadays, the worldwide spread of β-lactamase-pro-ducing organisms is an 
important public health threat. Metallo-β-lactamases, enzymes containing approximately 230 residues, are 
clustered into three different subclasses, B1, B2, and B3.
1
 Sequence identity ranges from 0.40-0.25 in one 
subclass and from 0.20-0.10 between subclasses. Subclass Bl enzymes have been found in strains of Bacillus, 
Bacteroides, Pseudomonas, Serratia, and Chryseobacterium, and subclass B3 enzymes have been found in 
strains of Stenotrophomonas, Legionella, Fluoribacter, Janthinobacterium, and Caulobacter. Both the Bl and B3 
subclasses have a broad-spectrum profile (including penicillins, cephalosphorins, and carbapenems) and, in vitro, 
require two zinc ions for maximal enzymatic activity. However, metallo-β-lactamases can display different 
metal-binding affinities for zinc ion and, at low concentrations (picomolar range) of free zinc appear to be active 
with a single zinc ion per monomer.
2
 Subclass B2 enzymes have a narrow substrate profile, hydro-lyzing 
carbapenems almost exclusively. These carbapenemases are produced by various species of Aeromonas and are 
active only in the monozinc form.
3
 In contrast to the situation with serine-β-lactamases, no clinically approved 
metallo-β-lactamase inhibitor is available. 
X-ray structures have been reported for enzymes of subclasses B1 and B3,
4-8
 and all show the existence of a 
binuclear zinc active site. The Zn1 site is formed by a triad of histidine residues in both subclasses, whereas the 
Zn2 site is formed by an Asp-Cys-His triad in subclass B1 and by Asp-His-His in subclass B3. Interestingly, on 
the basis of sequence alignments, subclass B2 proteins have Asn-His-His and Asp-Cys-His triads for the Zn1 site 
and the Zn2 site, respectively. 
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To obtain a better understanding of the metallo-β-lactamase family and of their catalytic mechanism, we have 
produced the first crystal structures of the wild-type (WT) and N220G mutant forms of the subclass B2 
Aeromonas hydrophila enzyme CphA. These structures reveal that this enzyme has a single zinc ion in the active 
site, located in the Zn2 site. Furthermore, by forming a complex of CphA and the antibiotic biapenem (Scheme 
1), we were able to trap a reaction intermediate. This is the first crystal structure of a metallo-β-lactamase with 
an antibiotic molecule bound in the active site. 
Results 
Wild-type CphA structure 
Aeromonas hydrophila CphA consists of 227 amino acid residues with a calculated molecular mass of 25.2 kDa. 
Since crystals of the WT CphA protein could not be obtained, ten single-site mutants were engineered by site-
directed mutagenesis and overproduced. The mutants were selected in order to introduce residues that are 
conserved in either subclass B1 or B3, or in both. The N220G mutant crystallized in a few days, allowing us first 
to solve the structure of the mutant, then to grow WT crystals. The kinetic parameters of the WT and N220G 
mutant enzymes were not significantly different, indicating a good conservation of the WT functional properties 
for the mutant (Table 1). The structure of the WT protein was solved by molecular replacement using the CphA 
mutant structure as the starting model and was refined to a resolution of 1.7 Å. The R-factor and Rfree for the 
refined structure were 0.19 and 0.20, respectively. The crystals adopt a C2221 space group with one molecule in 
the asymmetric unit. The crystallographic and model statistics for the WT and N220G mutant structures, together 
with that for the biapenem-CphA complex, are reported in Table 2. 
The model of the WT structure includes 224 amino acid residues (41-304, using the BBL numbering),
1
 the 
catalytically essential zinc ion, one carbonate anion located in the active site, one sulphate ion, and 178 water 
molecules. The electron density for Pro305 (excluding the N backbone atom) and for the last two residues of the 
polypeptide chain was not interpretable. 
CphA is a monomeric globular protein having the general αββα fold as described (Figure 1).4 Four β-strands (β1, 
β2, β3, and β4), two helix-strand elements (α1β5 and α2β6), one long α-helix (α3), and the β7 strand form the N-
domain, while four β-strands (β8, β9, β10, and β11) one 310 helix, the α4 helix, the βl2 strand, and the α5 helix 
form the C-domain. The N and C-domains face each other through sheets β1-7 and β8-12. The α1 and α2 helices 
of the N-domain and helices α4 and α5 of the C-domain are located externally on opposite faces of the β-strand 
core. In contrast to all reported Bl and B3 subclass structures, a long α3 helix is located near the active-site 
groove. The α3 helix, formed by residues Arg140-Leu161, has a kink, which allows the helix to follow the 
curvature of the protein. The helix is followed immediately by an unusual proline-rich loop (Pro162, Pro165, 
Pro168, and Pro172). Comparison of the fold for one representative of each subclass is represented in rainbow-
coloured ribbon in Figure 2. Only non-conserved secondary structures in the three subclasses are labelled to 
highlight structural differences in the superfamily. 
 
Table 1. Kinetic parameters of the wild type and selected mutants of CphA 
 Imipenem Biapenem 
Enzyme kcat (s
-1














Wild-type 1200 340 3.5 x 10
-6
 300 166 1.8 x 10
-6
 
N220G 390 50 7.8 x 10
-6
 160 118 1.3 x 10
-6
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Table 2. Data collection, phasing and refinement statistics 
 CphA CphA HgMAD CphA-biapenem 





A. Data collection statistics 
Wavelength (Å) 0.9795 0.9797 1.00783 1.01082 1.54179 
Resolution (Å)
a
                  23.6-1.70 (1.79-1.70) 58.9-1.60 (1.69-1.60) 58.7-1.65 58.7-1.65 26.5-1.90 (1.96-1.90) 
Unique reflections 27,567 32,222 30,753 30,720 20,636 
Space group C2221 C2221 C2221 C2221 C2221 
Unit cell dimensions 
a (Å) 42.63 42.67 42.69 42.72 42.83 
b (Å) 101.21 101.08 101.40 101.38 101.51 
c (Å) 118.23 117.36 117.26 117.32 117.36 
Completeness
a
 (%) 94.7 (94.7) 93.1 (93.1) 96.0 (96.0) 97.0 (97.0) 99.9 (99.9) 
Multiplicity
a
 3.5 (3.0) 5.8 (3.4) 6.4 (3.9) 6.3 (4.9) 5.9 (5.2) 
Rsym
a,b
 (%) 12 (31) 5 (7) 5 (8) 4 (9) 12 (29) 
I/σ(I)a 3.9 (1.8) 8.7 (8.1) 11.1 (7.4) 12.6 (6.6) 3.7 (2.1) 
B. Phasing statistics 
Heavy-atom sites   1 1  
FOM (centric/acentric)  0.66/0.78    
C. Refinement statistics 
R-factor/Rfree
c,d
 (%) 18.5/20.3 15.6/18.1   15.4/18.5 
R.m.s. deviations 
Bond lengths (Å) 0.017 0.011   0.017 
Bond angles (deg.) 1.63 1.36   1.75 
Number of atoms      
Protein 1759 1775   1759 
Zn 1x1 1x1   1x1 
Carbonate 1x4 1x4   - 
Biapenem - -   1x25 
Sulphate 1x5 3x5   6x5 
Glycerol - 2x6   1x6 




Protein 15.9 12.2   18.1 
Zn 13.9 10.5   17.8 
Carbonate 24.5 23.9   - 
Biapenem - -   23.9 
Sulphate 33.7 32.5   35.0 
Glycerol - 33.7   42.3 
Water 23.7 23.3   26.6 
a Numbers in parentheses are for the highest-resolution shell. 
b Rsym = ∑|I(hkl) - I(hkl) |/∑ I(hkl) . 
c R-factor = ∑|Fo(hkl) - Fc(hkl)|/∑|Fo(hkl)|. 
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Figure 1. Stereo view of the three-dimensional structure of the wild-type Aeromonas hydrophila CphA metallo-
β-lactamase. α-Helices are shown in red, the 310 helix in orange, strands in cyan, and loops in yellow. The zinc 
ion is represented as a green sphere. The triad of zinc ligands D120, C221, and H263, together with the 
carbonate ion bonded to the metal ion, are shown. 
 
 
Figure 2. Ribbon representations of the three subclasses; (a) BCII from Bacillus cereus, (b) this work and (c) 
FEZ-1 from Fluoribacter gormanii. The ribbon is coloured along the sequence on a residue-per-residue basis by 
a rainbow colour ramp. Secondary structure elements not conserved in one subclass are labelled. Zinc ions are 
represented as a grey sphere. 
 
 
The ψ/φ angles of Tyr60, Thr86, Ala195, Asn220, and Asp264 are located in the disallowed areas of the 
Ramachandran plot. The last three are adjacent to an amino acid involved in one of the zinc-binding sites (Zn1 or 
Zn2) and, in most other sequences, are glycine residues. Tyr60 is on a loop connecting two β-strands (β2 and 
β3), which force Tyr60 to adopt a strained conformation (ψ = 58°; φ = -123°). Thr86 is on a loop connecting β4 
to α1 and is adjacent to Trp87. A group of hydrophobic side-chains (Tyr59, Val67, Trp87, Tyr164, Pro165, and 
Phe236), together with other side-chains located on the α3 helix (Ile153, Phe156, and Leu161), appear to form a 
"hydrophobic wall", which defines the active site. Ala 195 (ψ = -160°; φ = -160°) is located on a loop between 
strands β8 and β9, which, at its apex, bears His196, which is involved in the active-site hydrogen bond network. 
Asn220 is the first residue of the 310 helix and precedes the zinc-coordinating residue, Cys221, while Asp264 
follows another zinc-coordinating residue, His263. Both Asn220 and Asp264 have a strained conformation of 
about ψ = 60° and φ = -160°. Another important residue in the CphA structure is Gly84. All available B2 
subclass sequences show a glycine residue at position 84, while B1 and B3 subclass enzymes have a buried Asp 
(or exceptionally an Asn), which adopts a strained conformation.
8
 Gly84 interrupts the β4 strand and turns the 
protein backbone through 90°, creating a hole inside the CphA structure that is occupied by a buried water 
molecule close to the Glu69 and Arg121 side-chains. The water molecule has a low B-factor (9 Å
2
) and makes 
three hydrogen bonds: two with backbone atoms (the nitrogen atom of Thr40 and the carbonyl oxygen atom of 
Asp90) and one with the hydroxyl group of Ser25. Those bonds should increase the stability of the protein. In the 
CphA structure, there are four buried charged residues, Asp57, Glu69, Arg121, and Asp199, the first three of 
which lie close together. Glu69 and Arg121 form a salt-bridge, while Asp57 and Glu69 form a very short 
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hydrogen bond (2.5 Å), indicating the presence of a shared hydrogen atom between the two side-chains. The 
side-chains of Asp57 and Glu69 bridge the β2 and β3 strands, but these residues are not conserved in the other 
sequences. Asp199, conserved in subclasses B1 and B2, makes two hydrogen bonds with the Thrl42 and Thr197 
side-chains. The importance of Arg121 and Asn220 is discussed in the following section. 
Secondary structure elements bear two of the three residues involved in zinc coordination, Asp120 in the α2 
helix and Cys221 in the 310 helix. The third residue, His263, is located on the loop connecting β12 and β13 
(Figure 1). The distances between the Zn atom and the Asp120 carboxyl oxygen atom, the Cys221 sulfur atom, 
and the His263 side-chain nitrogen atom are 1.96 Å, 2.20 Å, and 2.05 Å, respectively. Finally, a carbonate ion is 
bonded to the zinc (2.09 Å), and the four coordinating atoms, from Asp120, Cys221, His263, and O1 of CO3
2-
, 
generate a tetrahedral geometry around the metal ion. 
It is interesting to note that the first reported metallo-β-lactamase structure shows the zinc ion in site Zn1.4 
However, since the crystal structure of WT CphA was obtained from a crystal soaked in a solution containing a 
large excess of Zn
2+
 (10 mM), the presence of a single zinc ion in site Zn2 suggests that the monozinc species 
represents the native form of the B2 enzyme, CphA. 
The N220G mutant structure 
The refined structure of the mutant is essentially similar to that of the WT. The root-mean-square (r.m.s.) 
deviation between the C
α
 atoms of the two structures is 0.16 Å. Better-diffracting crystals allowed us to model 
the position of all 227 residues of the protein in the electron density map. Furthermore, the model contains one 
zinc ion, a carbonate ion located in the active site, three sulphate anions, two glycerol molecules, and 263 water 
molecules. The structure of the mutant shows two main features not seen in the structure of the WT enzyme. The 
first is that the N220G mutation leads to a localized conformational change in the protein backbone involving 
mainly residues Tyr218-Gly220 (Figure 3). In the WT structure, the last residue of β11, Tyr218, has backbone 
angles of φ = - 79° and ψ = 122°. Asn220 is the first residue of the 310 helix, and Gly219 connects these two 
secondary structure elements. In the mutant structure, Gly220 increases the flexibility of the protein backbone, 
Tyr218 turns to φ= -114°, ψ = 133° and allows the Tyr218 hydroxyl group to form a hydrogen bond with the 
Val203 backbone nitrogen atom; two water molecules occupy the volume no longer occupied by the Asn220 
side-chain. The second feature is a consequence of the previous one. The increased backbone mobility due to the 
N220G mutation alters the ability of Cys221 to coordinate the zinc ion. As a consequence, the zinc ion occupies 
two sites that are 1.5 Å apart, the WT site and the new site, with respective occupancies of 0.75 and 0.25 (Figure 
2). In the new site, the zinc ion again presents a tetrahedral geometry with the Asp120-Cys221-His263 triad, but 
the fourth coordinating atom is NH2 of the buried Arg121. The distance between NH2 and the zinc in the new 
site is 2.3 Å and, surprisingly, the Arg121 side-chain seems to act as an electron donor for the zinc. Such 
coordination is unusual in proteins. To look for an example in small molecules, the Cambridge database
9
 was 
searched, yielding the X-ray structure of a 1:1 complex between [(2-guanidinyl)ethyl-cyclen] and zinc, which is 
stable in aqueous solution at pH 7.5. In this small molecule complex, four nitrogen atoms of a cyclen ring and a 
nitrogen atom of guanidine in an imine form coordinate the zinc ion. In the WT and mutant CphA structures, the 
buried Arg121 side-chain makes several hydrogen bonds in the core of the protein with Glu69, Asn70, Tyr218, 
and Gly262 (Figure 3). Interestingly, in the mutant CphA structure, the buried Arg121 maintains all hydrogen 
bonds, whatever the position of the zinc. The guanidine group of the free arginine has a pKa of around 12.5. The 
local environment inside the enzyme may significantly lower the pKa value to generate the imine form of the 
guanidine group, which explains the observed coordination for zinc with a low occupancy. 
The CphA-biapenem complex structure 
Crystals of the CphA-biapenem complex were obtained by soaking crystals of the N220G mutant in mother 
liquor containing the antibiotic. The structure was solved by molecular replacement and, after refinement of all 
protein atoms, a difference electron density map (|Fcomplex| - |Fmutant|) was calculated,where |Fcomplex| and |Fmutant|   
are  the structure factor amplitudes of the mutant crystal soaked in solution containing biapenem and of the 
mutant crystal alone, respectively). A well-defined electron density in the active site could not be interpreted as 
either a biapenem or a hydrolyzed biapenem molecule. The presence of two fused rings near the zinc ion was an 
unexpected finding (Figure 4). In order to shed light on this observation, substrate and product inhibition studies 
were initiated. The kinetic data clearly support the model of product inhibition with Ki values of 320 µM and  
300 µM (±10%) for the WT and N220G enzymes, respectively. Both map interpretation and kinetic data agree 
with the presence of an intermediate in the hydrolysis reaction. The complex with the WT enzyme was prepared; 
however, the extra electron density in the active site was weaker, indicating a lower occupancy of the ligand 
bound to the enzyme. The refined CphA-biapenem complex structure comprises 227 protein residues, one zinc 
ion, six sulphate anions, and the intermediate molecule located in the groove of the active site with full 
occupancy. The r.m.s. deviation between the C
α
 atoms of the complex and mutant structures is 0.17 Å. 
Superimposition of the two structures shows that the binding of the intermediate induces a very localized 
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conformational change (G232-N233) in the active site (Figure 4). The intermediate is bonded to the zinc ion 
located at the WT position. The distance from the nitrogen atom of the β-lactam ring (N4) to the Zn2+ is 2.22 Å 
(Table 3). N4 also forms a hydrogen bond with Wat11 (2.9 Å) (Figure 5), which, in turn, forms hydrogen bonds 
with Asp120 and His118. The distance between Watll and the zinc atom is 3.39 Å. It was immediately clear 
from the first difference electron density map that the β-lactam ring had been cleaved between N4 and C7. 
 
Furthermore, the map clearly indicated the presence of two free carboxyl groups in positions C3 and C7 (Figure 
4). 
 
Figure 3. Stereo view of the active site of the N220G CphA mutant showing the backbone conformational 
change and the zinc coordination environment. The Y218-C221 residues of the wild-type CphA are coloured in 
magenta and superimposed for comparison. The two partially occupied positions of the zinc ion in the mutant 
are shown. The "natural" coordination position of zinc with occupancy 0.75 has D120, C221, H263, and a 
carbonate ion as ligands. The second coordination position with occupancy 0.25 has D120, C221, H263, and 
R121 as ligands. Water molecules referred to in the text and the hydrogen bond network in the active site are 
shown. 
 
Table 3. Interactions of the Zn ion and the intermediate with CphA 
Intermediate CphA Distance (Å) 
Zn D120 OD2 2.03 
 C221 SG 2.27 
 H263 NE2 2.12 
 O32 2.39 
 N4 2.22 
N4 Wat11 2.9 
 H263 NE2 2.9 
 L224 NZ 3.1 
O31 N233 NE2 3.1 
 L224 NZ 2.9 
 L224 NZ 2.9 
O71 T119 OG1 3.1 
 T157 OG1 2.9 
O62 H196 NE2 3.0 
 H196 NE2 3.0 
S21 His263 3.6 
Cl W87 CH2 4.1 
C62 N233 CB 3.8 
 F236 CD2 3.7 
 H118 CE1 4.2 
C22 G232 CA 3.9 
C25 V67 CG1 3.7 
C29 V67 CG1 3.3 
C25 H263 CG 4.0 
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Figure 4. The Fo — Fc map (blue) at 2σ corresponding to the area of the complex structure where the enzyme-
modified biapenem molecule was modelled. The phases were calculated from coordinates not completely refined 
without biapenem or solvent molecules in the active site. Final refined coordinates of modified biapenem, zinc, 
Wat11, D120, C221 and H263 residues have been superimposed. 
 
 
The C3 carboxyl group forms strong hydrogen bonds with the Lys224 side-chain nitrogen atom and the Asn233 
backbone nitrogen atom. The C7 carboxyl group formed after antibiotic hydrolysis makes two hydrogen bonds 
with the two hydroxyl groups of Thr119 and Thr157. Surprisingly, both C2 and C3 of the intermediate exhibit 
sp
3
 hybridization, showing that the molecule in the active site has lost the C2=C3 double bond. The side-chains 
containing the sulfur atom and the C3 carboxyl group are in the cis configuration. The biapenem is hydrolyzed 
and has lost the double bond, and it has undergone an internal molecular rearrangement. In fact, the electron 
density map shows a continuous density linking C3 to the oxygen atom of the C6 1-hydroxyethyl group, forming 
a six-membered ring fused to the hydrolyzed β-lactam ring (Figure 4). As the presence of a C2=C3 double bond 
and a C6 hydroxyethyl group are two main features of the carbapenem antibiotics currently in clinical use, we 
propose that a similar internal rearrangement may be common to all carbapenems. The intermediate in the active 
site is stabilized by several hydrophobic contacts. The biapenem sulfur atom interacts with the His263 ring, 
inducing a small rotation of its plane; the 1β-methyl group is in van der Waals contact with the side-chains of 
Trp87 and Val67, and the methyl group of the C6 1-hydroxyelthyl forms hydrophobic contacts with Phe156, 
Phe236 and the Asn233 side-chain carbon atom. In particular, the position of the Phe156 and Phe236 side-chains 
seems to preclude the possibility of having any bulkier group in C6 and retaining an efficient interaction between 
the intermediate and the enzyme. The biapenem σ-symmetric bicyclotriazoliumthio moiety is inserted between 
the Val67 side-chain and Gly232. Furthermore, its positively charged nitrogen atom interacts strongly with a 
water molecule located outside the active site (Figure 5). 
 
Figure 5. Stereo view of the active site of CphA in complex with modified biapenem (carbon atoms colored in 
orange). The conformational change upon substrate binding is represented by superimposition of the wild-type 
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Figure 6. The van der Waals surface of CphA in complex with modified biapenem (carbon atoms colored in 
orange). The zinc ion is represented as a green sphere. 
 
 
Upon biapenem binding, the Asn233 ψ angle changes from -18° to +121°, and this rotation orients the amide 
group of the Asn233 backbone towards the interior of the active site, allowing interaction with the C3 carboxyl 
group. As a result of the Asn233 side-chain rotation, the entrance to the active site is closed and Gly232 comes 
closer to the biapenem bicyclotriazoliumthio group. Furthermore, the Asn233 side-chain oxygen atom forms a 
hydrogen bond with the Ser235 hydroxyl group, stabilizing the closure of the loop. As a consequence, the 
"hydrophobic wall" from the N-domain and the mobile loop from the C-domain trap the antibiotic in the active 
site pocket, leaving only the terminal portion of the biapenem bicyclotriazoliumthio group outside the pocket 
(Figure 6). These interactions between the intermediate and the active site of the enzyme show that the active-
site groove of CphA is designed perfectly for a carbapenem molecule. 
Proposed reaction pathway 
Comparison of the three new structures suggests how subclass B2 metallo-β-lactamases recognize carbapenem 
antibiotics and allows detailed mechanistic proposals for antibiotic hydrolysis (Figure 7). In the resting state, the 
enzyme has a carbonate ion at its active site (Figure 3), bonded to the positively charged zinc ion and the Lys224 
side-chain. The Gly232-Asn233 loop located at the entrance of the active site that has been implicated in 
substrate binding is in the open position. The side-chains of His118 and His196, which are ligands of Zn1 site, 
are involved in a hydrogen bond network with water molecules and appear to aid in holding the carbonate ion in 
place. A carbonate ion was found in the B. cereus metallo-β-lactamase structure (PDB code 1BVT) and in leucyl 
amino-peptidase (PDB code 1LAM), another zinc hydrolase. For the CphA enzyme, the inhibition constant is 
rather high (KD 13( ± 2) mM), suggesting no physiological role for the carbonate ion. In the structure of the 
CphA-biapenem complex, eight hydrogen bonds between the carbapenem molecule and the protein as well as 
two bonds with the zinc ion are observed (Figure 7e and Table 3). The former involve the side-chains of Thr119, 
Thr157, His196, and Lys224, the nitrogen backbone of Asn233, and Wat11. Intermediate structures (Figure 7a-
d) were modeled on the basis of the X-ray structures of native and biapenem-complexed proteins, allowing only 
a rotation of side-chains (Figure 7b). The presence of a carbapenem molecule in the active site leads to the 
closure of the external loop, trapping the antibiotic. In the structure of the complex (Figure 7e), the C3 carboxyl 
group makes a bond with the zinc ion, and interacts with the NH3
+
 of Lys224, and the Asn233 nitrogen 
backbone, the last of which is brought into the correct orientation by the loop closure. Thr119 and Thr157 form 
hydrogen bonds with, and Phe156 and Phe236 form hydrophobic interactions with, the hydro-xyethyl group, 
which helps to stabilize and orient the antibiotic molecule. Substrate binding promotes the polarization of the β-
lactam ring carbonyl oxygen atom by His196 (Figure 7a). The Asn116 side-chain nitrogen atom and the Thr197 
hydroxyl group form hydrogen bonds with the His196 side-chain nitrogen atom. This hydrogen bonding network 
allows His196 to partially donate its hydrogen atom to the β-lactam ring carbonyl oxygen atom. A water 
molecule, activated by His118, attacks the carbonyl carbon atom and cleaves the β-lactam bond. As a 
consequence, N4 of carbapenem bonds to the zinc ion. The Zn
2+
 also helps in the correct orientation of the β-
lactam ring during hydrolysis (Figure 7b and c). 
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The carboxyl group generated by the hydrolytic process is stabilized initially by His196, Asp120, and His118 
(Figure 7b) but, after rotation around the C5-C6 bond, these interactions are replaced by those observed in the 
complex (Figure 7c) between the carboxyl group and Thr119, Thr157. Interestingly, the incoming water 
molecule (Watll) is located in a position suitable for promoting the protonation of the lactam nitrogen atom, 
which will weaken the interactions with the zinc ion (Figure 7c). At the last step of the catalytic reaction (Figure 
7f), the hydrolyzed carbapenem molecule can leave the active site. Finally a shorter pathway is possible between 
the intermediate (Figure 7c) and the product models (Figure 7f). However, in the present experimental 
conditions, the kinetic parameters support the longer one. The tautomeriza-tion between an enamine and an 
imine form of the β-lactam ring allows the transfer of a proton from the hydroxyethyl group OH to C2, followed 
immediately by nucleophilic attack on C3 by the oxygen atom of the same side-chain. The presence of the 
carboxylate group will render the imine group electron-deficient, promoting nucleophilic addition. The 
cyclization process appears to be supported strongly by the proximity of the Zn
2+ 
(Figure 7d). Another interesting 
observation is that the active site of CphA is fully occupied by the intermediate (Figure 6), leaving no space for 
further water molecules in the proximity of Wat11, the closest being the buried Wat43, which forms hydrogen 
bonds with His196, Asn116, and Thr197. The position of Wat43 suggests a possible way of access of water 
molecules to the zinc catalytic center during hydrolysis. 
Discussion 
Here, we report the first structures for a member of metallo-β-lactamase subclass B2 in both the native and 
mutant forms and in the form of a complex with an intermediate generated during hydrolysis of a carbapenem 
antibiotic. The overall general architecture of CphA is similar to that of enzymes of the other subclasses. 
However, it has an elongated helix (α3) located just above the active-site pocket. The α3 helix is a key element 
of the hydrophobic wall that defines the active-site pocket. In subclass B1, there is a long loop between β2 and 
β3, which is disordered in the native structure, but is stabilized upon binding of inhibitor.11 This long loop is 
missing from subclasses B2 and B3. However, compared to subclass B2, subclass B3 enzymes have a shorter 
insertion between α3 and β7, also forming a mobile loop near the active site. Consequently, in CphA, we observe 
a very well defined active site, which explains the very narrow activity profile of the enzyme. CphA is 
mononuclear, the zinc ion being located in the Zn2 site, whereas, in all other structures known, two zinc ions can 
be bound and, if a functional monozinc enzyme can be produced in the native form, the zinc ion is located in the 
Zn1 site. In CphA, as hypothesized, even in the presence of a large excess of zinc, ligands in positions 116, 118, 
and 196 (Zn1 site) do not interact with any zinc ion. Instead, Asn116, His118, and His196, together with Lys224, 
form a hydrogen bond network in the active site involving several water molecules. This could be due to the 
His116Asn mutation seen in subclass B2. GOB-1, a subclass B3 enzyme, harbors Gln116 and may therefore be a 
monozinc enzyme. Finally, an excess of zinc results in a loss of enzymatic activity. Although the dissociation 
constant of the second zinc ion is about 50 µM, we did not observe the binding of a second zinc ion, even at a 
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very high concentration of zinc in the mother liquor. This apparent discrepancy might result from the presence of 
a carbonate ion in the active site and/or the conditions used to grow crystals. Indeed, the residues in the putative 
Znl site are not positioned adequately to bind Zn in the native enzyme and solution NMR measurements indicate 
major conformation changes upon binding of the second zinc ion (C. Damblon, personal communication). 
Attempts to obtain substrate complexes or convincing information about modes of substrate binding using 
docking procedures have always failed for B1 and B3 enzymes.
7,11,13
 Recently an interesting report was 
published on simulations of substrate binding to the mononuclear B. cereus metallo-β-lactamase.14 Using a high 
concentration of substrate in the crystallization drop, we succeeded in trapping an intermediate filling the narrow 
active-site pocket of CphA. Previous failures with subclass B1 and B3 enzymes could be due to the presence of a 
long active-site cleft covered by a mobile loop. 
In metallo-β-lactamases containing two zinc ions, the catalytic mechanism of β-lactam hydrolysis has been 
proposed to involve a bridging hydroxide group located between the two zinc ions, which can serve as the 
attacking nucleophile on the carbonyl oxygen atom of the β-lactam ring.5,7,15 In this mechanism, Znl would 
polarize the carbonyl oxygen atom. However, it has been suggested that under physiological conditions and in 
the presence of substrate, metallo-β-lactamases would act as monozinc enzymes,2 but it is not known whether the 
zinc is in the Zn1 or the Zn2 site or partially in both. For the CphA enzyme, the dissociation constants for the 
binding of zinc ions in the presence or absence of substrate are 1.2 pM and 7.0 pM, respectively
2
 and the present 
structures show that the zinc ion is located in the Zn2 site. These results support earlier finding demonstrating a 
full occupancy of a single zinc ion with a Cys sulphur atom as a ligand.
3,16
 So, for the first time in the metallo-β-
lactamase family, we have determined the structure of the enzyme as it is under the expected physiological 
conditions. The first reported structure of the family reveals a monozinc enzyme with the ion located in the Zn1 
site. On the basis of the observed active-site geometry, a catalytic mechanism was proposed by analogy to the 
zinc peptidases,
4
 in which the zinc ion has a dual role in catalysis. Firstly, a zinc-bound water molecule is 
activated to perform a nucleophilic attack on the β-lactam carbonyl group. Secondly, the zinc ion binds and 
polarizes this carbonyl group. Asp120 participates in the activation of the water molecule. A more recent 
publication analyses the proposed catalytic mechanism on the basis of the pH-dependence of the hydrolysis rate 
and kinetic constants.
17
 This mechanism and our proposed mechanism for CphA are completely different. 
However, since the active sites of the B. cereus and CphA enzymes are quite different, it is reasonable to 
hypothesize that the β-lactam hydrolysis proceeds according to different mechanisms in the two enzymes. 
In conclusion, the three reported structures reveal one molecular mechanism of β-lactam hydrolysis by subclass 
B2 metallo-β-lactamases and may help in designing small molecules for specific therapeutic applications. 
Materials and Methods 
Protein purification and crystallization 
Site-directed mutagenesis, protein expression at 18 °C and purification of the proteins were performed as 
described.
18
 The purified enzyme solution was dialyzed against 15 mM sodium cacodylate (pH 6.5). As 
measured by inductively coupled plasma-mass spectrometry (ICP-MS), the WT and mutant enzyme contained 
one zinc ion per molecule. Initial screening experiments were performed by a TECAN Genesis robot using 
commercial Hampton crystallization screens. N220G CphA (~10mg ml
-1
) was crystallized at 8 °C from 30-34% 
(w/v) PEG8000, 0.6-0.8 M ammonium sulphate, and 100 mM sodium citrate (pH 6.5), using the hanging-drop 
method. The (2 µl) reservoir solution was mixed with the protein solution (2 µl) and the mixture was left to 
equilibrate against the reservoir solution. Typically, crystals grew within a few days to dimensions of 80 µm x 
l00 µm x l00 µm. Crystals of the WT protein were obtained under similar crystallization conditions using mutant 
micro-crystals as starting seeds. Before data collection, both the WT and the mutant crystals were transferred to 
drops of reservoir solution containing 10 mM ZnCl2 and soaked for one day. In order to obtain the mercury 
derivative, crystals of the mutant were instead washed using the reservoir solution for removing the excess of 
ZnCl2, and transferred to a drop of reservoir solution containing 1 mM sodium p-hydroxy-mercurio-benzoate. 
The biapenem-CphA complex was obtained by adding an excess of biapenem powder directly to a drop 
containing mutant CphA crystals. 
Data collection and processing 
A mercury derivative crystal was transferred to cryoprotectant solution (reservoir solution containing 20% (v/v) 
glycerol), while WT and mutant crystals were transferred to cryoprotectant solution containing 10 mM ZnCl2, 
then the crystals were mounted rapidly in loops and flash-cooled. X-ray data for the WT and for the mutant 
CphAs were collected at the European Synchrotron Radiation Facility at the BM30A beam-line. X-ray data for 
the biapenem-CphA complex were obtained in-house using a Nonius FR591 rotating anode X-ray generator 
coupled to a Mar Research Imagine Plate detector. Data were processed using CCP4 programs (MOSFLM and 
SCALA)
19
 (Table 2). 
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Structure determination and refinement 
The structure of mutant CphA was solved using the single isomorphous replacement with anomalous scattering 
(SIRAS) method, in which phases to 1.7 Å were generated using data from the inflection and peak of the 
mercuric derivative and data from the mutant. One mercury atom was located in the asymmetric unit using 
SOLVE.
20
 Phase refinement resulted in a figure of merit (FOM) of 0.60 and yielded a partially interpretable map. 
Density modification and automatic building using RESOLVE
21
 resulted in a model that included 81% of the 
sequence. Multiple rounds of model building with O
22
 and refinement with REFMAC gave the final structure. 
The crystals of native and complexed CphA were isomorphous with the mutant crystals. Initial phases for the 
native and complexed structures were obtained using the structure of the mutant as the starting model. 
Refinement was carried out using O and REFMAC. For the complex, the calculation of the first (Fo—Fc) 
electron density map clearly showed the presence of the antibiotic molecule in the active site. Biapenem was 
modeled in the map after most of the protein main-chain and side-chain atoms and most of the water molecules 
were built and refined. Conformational torsion angle restraints and charge assignments for the intermediate 
molecule were obtained using CCP4i Libcheck. The refinement statistics for all structures are shown in Table 2. 
Enzyme kinetics 
Kinetic parameters were determined routinely on the basis of initial rate measurements at 30 °C and in 15 mM 
sodium cacodylate (pH 6.5). Absorbance variations were monitored at 300 nm (∆ε= -9000 M-1 cm-1) and 294 nm 
(∆ε = -9960 M-1 cm-1) for imipenem and biapenem, respectively. Substrate concentrations ranged from 0.5 Km to 
2 Km. Above 250 µM, a 0.2 cm light-path cell was utilized. 
Product inhibition determination 
The kinetic parameters of the enzymes with biapenem as substrate were determined on the basis of both 
complete time-courses and initial rates. For both the WT and the mutant enzymes, the kcat and Km values were 
significantly lower according to the latter technique. This suggested an inhibition by the product.
23
 Indeed, after 
biapenem solutions were hydrolyzed completely, addition of a fresh substrate sample yielded initial rates lower 
than the original ones. 
Protein Data Bank accession codes 
Coordinates and structure factors have been deposited with the Protein Data Bank using accession codes 1X8G 
(wild-type), 1X8H (N220G mutant), and 1X8I (biapenem complex). 
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